Peripheral vascular reactivity and serum BDNF responses to aerobic training are impaired by the BDNF Val66Met polymorphism

Carregando...
Imagem de Miniatura
Citações na Scopus
32
Tipo de produção
article
Data de publicação
2016
Editora
AMER PHYSIOLOGICAL SOC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PHYSIOLOGICAL GENOMICS, v.48, n.2, p.116-123, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Besides neuronal plasticity, the neurotrophin brain-derived neurotrophic factor (BDNF) is also important in vascular function. The BDNF has been associated with angiogenesis through its specific receptor tropomyosin-related kinase B (TrkB). Additionally, Val66Met polymorphism decreases activity-induced BDNF. Since BDNF and TrkB are expressed in vascular endothelial cells and aerobic exercise training can increase serum BDNF, this study aimed to test the hypotheses: 1) Serum BDNF levels modulate peripheral blood flow; 2) The Val66Met BDNF polymorphism impairs exercise training-induced vasodilation. We genotyped 304 healthy male volunteers (Val66Val, n = 221; Val66Met, n = 83) who underwent intense aerobic exercise training on a running track three times/wk for 4 mo. We evaluated pre- and post-exercise training serum BDNF and proBDNF concentration, heart rate (HR), mean blood pressure (MBP), forearm blood flow (FBF), and forearm vascular resistance (FVR). In the pre-exercise training, BDNF, proBDNF, BDNF/proBDNF ratio, FBF, and FVR were similar between genotypes. After exercise training, functional capacity ((v)over dot(O2) (peak)) increased and HR decreased similarly in both groups. Val66Val, but not Val66Met, increased BDNF (interaction, P = 0.04) and BDNF/proBDNF ratio (interaction, P < 0.001). Interestingly, FBF (interaction, P = 0.04) and the FVR (interaction, P = 0.01) responses during handgrip exercise (HG) improved in Val66Val compared with Val66Met, even with similar responses of HR and MBP. There were association between BDNF/proBDNF ratio and FBF (r = 0.64, P < 0.001) and FVR (r = -0.58,P < 0.001) during HG exercise. These results show that peripheral vascular reactivity and serum BDNF responses to exercise training are impaired by the BDNF Val66Met polymorphism and such responsiveness is associated with serum BDNF concentrations in healthy subjects.
Palavras-chave
BDNF Val66Met polymorphism, exercise training, vascular reactivity
Referências
  1. Mortensen SP, 2009, HYPERTENSION, V53, P993, DOI 10.1161/HYPERTENSIONAHA.109.130880
  2. Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533
  3. Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009
  4. SULLIVAN MJ, 1989, CIRCULATION, V80, P769
  5. Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726
  6. EKLUND B, 1976, J PHYSIOL-LONDON, V262, P39
  7. BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020
  8. Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241
  9. Trombetta IC, 2003, AM J PHYSIOL-HEART C, V285, pH974, DOI 10.1152/ajpheart.01090.2002
  10. Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119
  11. Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728
  12. Lin CY, 2013, INT J MOL SCI, V14, P15459, DOI 10.3390/ijms140815459
  13. Dietz NM, 1997, J PHYSIOL-LONDON, V498, P531
  14. Hariri AR, 2003, J NEUROSCI, V23, P6690
  15. Reed AS, 2000, J PHYSIOL-LONDON, V525, P253, DOI 10.1111/j.1469-7793.2000.t01-1-00253.x
  16. Negrao CE, 2001, AM J PHYSIOL-HEART C, V281, pH469
  17. MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
  18. Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009
  19. Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024
  20. Hilberg T, 2003, EUR J APPL PHYSIOL, V90, P639, DOI 10.1007/s00421-003-0907-2
  21. Zoladz JA, 2014, J PHYSIOL PHARMACOL, V65, P441
  22. Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069
  23. ZELIS R, 1974, CIRCULATION, V50, P137
  24. Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43
  25. Zoladz JA, 2010, PHARMACOL REP, V62, P494
  26. Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168
  27. Alves CR, 2013, PHYSIOL GENOMICS, V45, P487, DOI 10.1152/physiolgenomics.00065.2012
  28. Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652
  29. Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8
  30. Lin CY, 2014, BIOCHEM PHARMACOL, V91, P522, DOI 10.1016/j.bcp.2014.08.008
  31. Osanai T, 2000, AM J PHYSIOL-HEART C, V278, pH233
  32. Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004
  33. Gorman MW, 2012, EXERC SPORT SCI REV, V40, P37, DOI 10.1097/JES.0b013e3182348cdd
  34. Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000
  35. Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
  36. POHL U, 1986, HYPERTENSION, V8, P37
  37. Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9
  38. Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106
  39. Lung CC, 1997, J ALLERGY CLIN IMMUN, V99, P134, DOI 10.1016/S0091-6749(97)81054-8
  40. Usui T, 2014, ACTA PHYSIOL, V211, P385, DOI 10.1111/apha.12249
  41. Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034
  42. Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003
  43. CohenSolal A, 1995, PRESSE MED, V24, P1806
  44. Ribeiro F, 2013, AM J PHYS MED REHAB, V92, P1020, DOI 10.1097/PHM.0b013e31829b4c4f
  45. Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118
  46. Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180
  47. Camm AJ, 1996, EUR HEART J, V17, P354
  48. Martins LB, 2015, NEUROSCI LETT, V587, P6, DOI 10.1016/j.neulet.2014.12.022
  49. Nascimento CMC, 2014, J ALZHEIMERS DIS, V43, P81
  50. Ribeiro F, 2009, INT J CARDIOL, V141, P214
  51. Souza C. A., 2000, CIRCULATION, V102, P1351
  52. Wasserman K, 1987, PRINCIPLES EXERCISE, P189
  53. WASSERMA.K, 1973, J APPL PHYSIOL, V35, P236
  54. Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467